Cargando…
Comorbidities are Frequent in Patients with Gastroesophageal Reflux Disease in a Tertiary Health Care Hospital
INTRODUCTION: Several aspects of gastroesophageal reflux disease (GERD) have been studied, but the frequency of comorbidities is not yet fully understood. OBJECTIVES: To study the prevalence of GERD comorbidities in a tertiary care hospital. METHODS: We prospectively studied 670 consecutive adult pa...
Autores principales: | Moraes-Filho, Joaquim Prado P, Navarro-Rodriguez, Tomás, Eisig, Jaime N, Barbuti, Ricardo C, Chinzon, Decio, Quigley, Eamonn M M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728193/ https://www.ncbi.nlm.nih.gov/pubmed/19690664 http://dx.doi.org/10.1590/S1807-59322009000800013 |
Ejemplares similares
-
INFLUENCE OF EXERCISE TESTING IN GASTROESOPHAGEAL REFLUX IN PATIENTS WITH
GASTROESOPHAGEAL REFLUX DISEASE
por: MENDES-FILHO, Antonio Moreira, et al.
Publicado: (2014) -
Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011) -
Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study
por: Navarro-Rodriguez, Tomás, et al.
Publicado: (2013) -
Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial
por: Eisig, Jaime Natan, et al.
Publicado: (2015) -
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
por: Eisig, Jaime N, et al.
Publicado: (2009)